Turn Therapeutics
Turn Therapeutics
Turn Therapeutics is a clinical-stage biotechnology company developing first-in-class topical therapies for inflammatory skin diseases, wound care, and infectious diseases.
About
What does Turn Therapeutics do?
Turn Therapeutics is a clinical-stage biotechnology and medical device development company focused on advancing non-systemic medicines for inflammatory skin diseases, wound care, and infectious diseases. The company's proprietary PermaFusion® drug delivery platform enables water-soluble therapeutic agents to penetrate deeper tissue layers, delivering localized treatment without systemic exposure or injections. Their lead candidate, GX-03, is in Phase 2 clinical trials for moderate-to-severe atop…
Is Turn Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Turn Therapeutics is 60 out of 100, based on site security posture and privacy practices.
What is Turn Therapeutics's revenue?
StartupHub estimates Turn Therapeutics's annual revenue at $1.3M (range $765K to $5.7M, 63% confidence), based on comparable companies in the sector.
Where is Turn Therapeutics headquartered?
Turn Therapeutics is headquartered in Westlake Village, United States.
When was Turn Therapeutics founded?
Turn Therapeutics was founded in 2015.
What industry does Turn Therapeutics operate in?
Turn Therapeutics operates in Biotech, MedTech, Drug Discovery, Dermatology, Wound Care, Infectious Disease.
How many employees does Turn Therapeutics have?
Turn Therapeutics has approximately 10 people on record.
AI precision medicine company transforming cancer diagnostics and patient outcomes through cutting-edge foundation models and multi-modal data.
Tryal develops eClinical software solutions that streamline and support clinical trial operations for pharmaceutical and biotechnology companies, CROs, and research sites.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
A web portal for precision tracking in performance biology, offering anonymous-first protocol design and immutable versioning.
Peak Peptides provides high-purity, third-party tested research-grade peptides for scientific research and laboratory use.
Olera is a Brazilian biotechnological skincare brand offering high-performance products with native Amazonian ingredients.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 9 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Scan this site yourselfStrength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.
Check any domain freeGoogle PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
Open in PageSpeed InsightsWhether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.
Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.
No comments yet. Be the first to share your take.